Mitchell Sinkler & Starr’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,030
| Closed | -$273K | – | 190 |
|
|
2024
Q4 | $273K | Hold |
3,030
| – | – | 0.07% | 143 |
|
|
2024
Q3 | $299K | Buy |
3,030
+860
| +40% | +$85K | 0.08% | 135 |
|
|
2024
Q2 | $212K | Buy |
2,170
+542
| +33% | +$52.9K | 0.05% | 148 |
|
|
2024
Q1 | $154K | Sell |
1,628
-5,897
| -78% | -$560K | 0.04% | 159 |
|
|
2023
Q4 | $672K | Buy |
+7,525
| New | +$672K | 0.12% | 116 |
|
|
2023
Q3 | – | Sell |
-5,955
| Closed | -$495K | – | 141 |
|
|
2023
Q2 | $495K | Sell |
5,955
-150
| -2% | -$12.5K | 0.14% | 96 |
|
|
2023
Q1 | $465K | Buy |
6,105
+617
| +11% | +$47K | 0.14% | 95 |
|
|
2022
Q4 | $456K | Buy |
5,488
+125
| +2% | +$10.4K | 0.15% | 102 |
|
|
2022
Q3 | $425K | Buy |
5,363
+660
| +14% | +$52.3K | 0.16% | 83 |
|
|
2022
Q2 | $349K | Sell |
4,703
-80
| -2% | -$5.94K | 0.13% | 91 |
|
|
2022
Q1 | $430K | Buy |
4,783
+655
| +16% | +$58.9K | 0.13% | 86 |
|
|
2021
Q4 | $462K | Sell |
4,128
-340
| -8% | -$38.1K | 0.14% | 87 |
|
|
2021
Q3 | $562K | Buy |
4,468
+323
| +8% | +$40.6K | 0.51% | 63 |
|
|
2021
Q2 | $561K | Buy |
4,145
+375
| +10% | +$50.8K | 0.51% | 63 |
|
|
2021
Q1 | $511K | Hold |
3,770
| – | – | 0.5% | 66 |
|
|
2020
Q4 | $531K | Hold |
3,770
| – | – | 0.51% | 63 |
|
|
2020
Q3 | $420K | Buy |
3,770
+230
| +6% | +$25.6K | 0.43% | 67 |
|
|
2020
Q2 | $396K | Hold |
3,540
| – | – | 0.45% | 65 |
|
|
2020
Q1 | $274K | Sell |
3,540
-600
| -14% | -$46.4K | 0.36% | 76 |
|
|
2019
Q4 | $394K | Hold |
4,140
| – | – | 0.42% | 69 |
|
|
2019
Q3 | $316K | Sell |
4,140
-2,650
| -39% | -$202K | 0.4% | 74 |
|
|
2019
Q2 | $596K | Buy |
6,790
+600
| +10% | +$52.7K | 0.68% | 52 |
|
|
2019
Q1 | $560K | Hold |
6,190
| – | – | 0.65% | 56 |
|
|
2018
Q4 | $444K | Buy |
6,190
+150
| +2% | +$10.8K | 0.55% | 61 |
|
|
2018
Q3 | $579K | Buy |
6,040
+750
| +14% | +$71.9K | 0.61% | 57 |
|
|
2018
Q2 | $504K | Buy |
+5,290
| New | +$504K | 0.56% | 63 |
|